Tele-rehabilitation program for patients with pulmonary sarcoidosis
Feasibility & Effect of a Tele-rehabilitation Program in Pulmonary Sarcoidosis
NA · Aarhus University Hospital · NCT03914027
This study is testing a remote exercise program to see if it can help people with pulmonary sarcoidosis improve their lung function and overall health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 26 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Aarhus University Hospital (other) |
| Locations | 1 site (Århus, Aarhus) |
| Trial ID | NCT03914027 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility and effectiveness of a tele-rehabilitation program designed for patients with pulmonary sarcoidosis, a condition that leads to reduced lung function and physical inactivity. The program aims to provide accessible physical training to improve pulmonary function and overall health outcomes for patients who are geographically dispersed. Participants will engage in a structured exercise regimen delivered remotely, addressing the lack of defined training protocols for this rare disease. The study will assess the impact of this approach on physical conditioning and quality of life.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with pulmonary sarcoidosis who meet specific pulmonary function criteria.
Not a fit: Patients with severe cardiac diseases, musculoskeletal disorders, or those unable to participate in tele-rehabilitation may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly enhance the physical health and quality of life for patients with pulmonary sarcoidosis.
How similar studies have performed: While tele-rehabilitation has shown promise in other chronic conditions, this specific approach for pulmonary sarcoidosis is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of PS * Signed informed consent * Adults ≥ 18 years * DLCO ≥ 30% predicted and FVC ≥ 50% predicted * 6 minute walking test distance ≥ 150 m Exclusion Criteria: * Participation in an official rehabilitation program \< 3 months before start of the study Musculoskeletal disorders * Severe cardiac diseases (ejection fraction \< 30%, daily angina, or otherwise specified by treating cardiologist) * Unable to understand informed consent * Other conditions that hamper the use of tele-rehabilitation * Non-Danish speaking. * Unwillingness to implement the protocol
Where this trial is running
Århus, Aarhus
- Pulmonary Disease Research Center — Århus, Aarhus, Denmark (RECRUITING)
Study contacts
- Principal investigator: Elisabeth Bendstrup, PhD, MD — Aarhus University Hospital
- Study coordinator: Jose Cerdan, PhD stud
- Email: joscer@rm.dk
- Phone: +4530648283
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Sarcoidosis, Pulmonary, Telerehabilitation